Home Page

DUBLIN, Aug. 14, 2018 /PRNewswire/ --

The "Sustained Release Injectables to 2024" report has been added to ResearchAndMarkets.com's offering.

Improved drug formulation tech-nology and sophisticated injection deices are converging to create opportunities for sustained release dosing. The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent dosing is believed to improve patient safety, reduce the incidence of injection site complications and improve compliance with drug protocols. Sustained release formulations mitigate the bolus effect at the time of injection, and thus have a salutary influence on drug side effects.

What You Will Learn

• What are the marketed sustained release injectable drug products, what sustained release formulation technologies are used, and who markets them?
• What are the major factors driving sustained release injectable drug demand?
• What sustained release injectable drug candidates are in late-stage clinical development and what is their potential impact?
• How important are drug developer-formulation technologist relationships in the sustained release market segment, and what are the key alliances in the industry?
• What are the essential formulation factors, delivery device selection issues, related technology factors and market development issues for sustained release injectable drug products?
• In what therapeutic market segments do sustained release injectables compete? What is their market share today? What will it be in 2022? What is their expected growth rate?
• What are the significant economic, technology, and regulatory factors affecting the market for sustained release injectables?

Report Value Matrix

• Managed Care Managers
• Management Consultants
• Financial Analysts
• Pharma Product Managers
• Device Suppliers
• Biotech Managers
• Product Developers
• Component Suppliers
• CMOs, CSOs
• Drug Marketers & Strategists
• Clinical Managers
• Drug Distributors
• Pharma Regulators

Key Topics Covered:

1. Executive Summary

• Injectable Drug Market Dynamics
• The Trend toward Self-Administration
• Injectable Drug Formulation Technology
• Innovation in Injectable Device Designs
• Therapeutic Demand Drivers
• Market Factors
• Competitive Landscape
• Risk Factors

2. Sustained Release - Branded Formulation Technologies

• Biodegradable Polymers
• Branded SR Formulation Technologies
• Physical Process Control Methods

3. Sustained Release Injectables - Development Factors

• Formulation Factors
• Stability
• Lyophilization
• Packaging
• Administration Factors

4. SR Injectables - Product Analysis & Market Sector Forecasts

• Addiction
• Infectious Disease
• Hormone Deficiency
• Metabolic Diseases
• Neurology
• Oncology
• Pain Management
• Reproductive Health

5. Development-stage SR Injectables

6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/dmw9dl/global_sustained?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-sustained-release-injectables-to-2024-the-trend-toward-self-administration-300696757.html

SOURCE Research and Markets